Related by context. All words. (Click for frequent words.) 64 Helps Ensure 63 Expanded 63 Significantly Expand 63 Broadens Its 63 Accelerates Growth 63 Diamyd Medical Diamyd 62 Cost Efficiencies 62 Boosts Productivity 62 Expands Scope 62 Quantifies 62 Achieves Significant 61 Product Offerings 61 Significantly Expands 61 Gains Traction 61 Tremendous Growth 61 Disaster Recovery Capabilities 61 Enables Easy 61 Pricing Structure 61 Rapidly Expanding 61 Integration Capabilities 61 Key Milestones 61 Customer Deployments 61 Study Reinforces 61 Reduced Costs 61 Strengthens Balance Sheet 61 Diversifies 61 Rapid Expansion 61 Patented Technology 61 Flagship Product 60 Significantly Improved 60 Improve Patient 60 Summarizes 60 Data Suggest 60 Helps Manage 60 Substantial Increase 60 Expands Globally 60 Acquisition Strengthens 60 Expanding Presence 60 Formalize 60 Provide Seamless 60 Sustained Growth 60 Major Step Toward 60 Increased Functionality 60 BioElectronics Corporation Announces 60 Subsidiary Expands 60 Provides Unprecedented 60 Multi Lingual 60 Merge Healthcare Announces 60 Patent Filing 60 Modifiable 60 Creates Opportunities 60 Broadens Product 60 Differentiates 60 Growing Rapidly 60 Significant Improvements 60 Flamel Technologies Announces 60 Successful Implementation 60 Significantly Improves 60 Continues Rapid 60 StockSource.us Reports USOG 60 Formalizes 60 Files Patent Application 60 Provides Detailed 59 Strengthens Leadership 59 Seamless Integration 59 License Pact 59 Continues Aggressive 59 Builds Momentum 59 Left Atrial 59 Zix Corporation Announces 59 Experiences Significant 59 Broadens 59 Dramatically Expands 59 Enhanced User Experience 59 Study Shows Significant 59 Sustain Growth 59 Rapidly Growing 59 Issues Resolved 59 Fingerprint Biometric 59 Injectable Drug 59 Maximizes 59 SABESP Announces 59 Expand Coverage 59 Technological Advances 59 Improve Customer Experience 59 Search Capabilities 59 Reveals Significant 59 Confirms Commitment 59 Extend Reach 59 Provide Comprehensive 59 Deliver Powerful 59 Provide Unprecedented 59 Diagnostic Tools 59 PRONTO Planning 59 Must Rethink 59 Expands Capabilities 59 Expands Coverage 59 Empowers Consumers 58 Improve Customer Satisfaction 58 Continues Steady 58 Regulatory Requirements 58 Further Validates 58 Reinforces 58 Viral Suppression 58 Improve Profitability 58 Positions Itself 58 Structural Changes 58 Margin Expansion 58 Pending Acquisition 58 Emphasizes Need 58 Present Preclinical Data 58 Innovative Approach 58 Supply Chain Efficiency 58 Per Cent Increase 58 Issues Clarification 58 Multi Billion Dollar 58 Momentum Grows 58 Ethical Considerations 58 Grows Rapidly 58 Aggressive Expansion 58 Sees Increased 58 Report Analyzes 58 Awarded GSA Schedule 58 Compliance Requirements 58 Intellectual Property Portfolio 58 Demonstrates Commitment 58 Gaining Acceptance 58 EHR Adoption 58 Core Competency 58 Hosts Webinar 58 Dramatic Increase 58 Estrogen Therapy 58 Imaging Technique 58 XPEL Announces 58 Becomes Easier 58 Wide Ranging 58 Widest Range 58 Idenix Novartis 58 Policies Procedures 58 Showcases Expanded 58 Significant Milestone 58 Significant Milestones 58 Hormonal Contraceptives 58 Appointment Scheduling 58 Adverse Outcomes 58 Treating Depression 58 Sees Steady 58 Underpins 58 Enters Into Exclusive 58 Poses Risk 58 Enables Faster 58 Lupus Drug 58 Sees Continued Growth 58 Maximized 58 PPO EPO 58 Speech Enabled 58 Reinforces Its 58 Strengthens Position 58 Implant Sciences Announces 58 Reinvigorates 58 Voice Enabled 58 Context Aware 58 Demonstrates Sustained 58 Genetic Tests 58 Offers Unmatched 58 Fortifies 58 Gaining Traction 58 Renal Cancer 58 Underpin 58 Rapidly Expands 58 Varies Widely 58 Enlarges 58 Announce Launch 58 Provides Comprehensive 58 Improves Accuracy 58 Testosterone Patch 58 Passes Milestone 58 Obtains Financing 57 Further Strengthens 57 Removes Barriers 57 Dramatically Increase 57 Announce Expanded 57 Accelerate Growth 57 Artificial Cornea 57 Flexpoint Announces 57 Epilepsy Drug 57 Refines 57 Licenses Patents 57 Accelrys Announces 57 Achieve Significant 57 Files IND 57 Accelerates Momentum 57 Functionalities 57 Performance Benchmarks 57 Formally Launches 57 WebTech Wireless Announces 57 ERP Implementation 57 Broadband Subscriber 57 Completes Reorganization 57 Demystifies 57 Facial Recognition Technology 57 Expands Internationally 57 Achieves Record Growth 57 Submits Application 57 Increased Scrutiny 57 Product Roadmap 57 Still Lags 57 Maintains Momentum 57 CNinsure Announces 57 Strengthen Relationship 57 Draws Mixed Reaction 57 Issues Shareholder 57 Announces Discontinuation 57 Formulates 57 Experts Advise 57 Provides Insights 57 Issues Surrounding 57 Receives Funding 57 Testing Capabilities 57 Dramatically Increases 57 Advanced Functionality 57 Dramatically Reduce 57 Emphasizes Importance 57 Helps Predict 57 Enhances 57 Significantly Enhances 57 BioElectronics Announces 57 Releases Findings 57 Expand 57 XO Communications Expands 57 Extends Reach 57 Expands Client Roster 57 Randomized Trials 57 Centralizes 57 Streamlines Operations 57 Study Evaluates 57 Vicor Technologies Announces 57 Announces Expanded 57 Novel Therapeutic 57 CorVel Announces 57 Multi Faceted 57 Demonstrates Positive 57 Penetrates 57 Quantifiable 57 Delivers Unprecedented 57 Significant Increase 57 HIPAA Compliant 57 Various Types 57 Powerful Tool 57 Accelerate Adoption 57 Email Deliverability 57 Significant Enhancements 57 Clinical Trial Data 57 RNAi Therapeutics 57 Dramatically Improves 57 Shows Promise Against 57 Unveils Enhanced 57 Exponential Growth 57 Completes Integration 57 Enhanced Version 57 Sixth Consecutive Quarter 57 Being Studied 57 Rapidly Evolving 57 Demonstrates Ability 57 Sees Positive 57 Key Enabler 57 Privacy Breaches 57 Digital Signage Networks 57 Launches Redesigned Website 57 Furthers 57 FDA Okays 57 Regulatory Approvals 57 Improves Patient 57 Delivers Comprehensive 57 Reexamine 57 Commence Immediately 57 Unveils Expanded 57 Hormonal Therapy 57 Strengthens Presence 57 Study Shows Benefits 57 Dry Powder Inhalers 57 Introduces Expanded 57 Interest Rate Increases 57 Establish Strategic 57 Enhanced 57 Deliver Optimized 57 Talks Underway 57 Transferable Skills 57 Drug Resistant Tuberculosis 57 PremierWest Bancorp Announces 57 Expedites 57 Seen Boosting 57 Gaps Remain 57 Momentum Continues 57 Offers Enhanced 57 Product Catalogs 57 Outlines Steps 57 Product Enhancements 57 Selects Kofax 57 Recurrent Breast Cancer 57 Expands Offerings 57 Gene Variation 57 Miraculins Announces 57 Maintains Strong 57 Author Explores 57 Helping Small Businesses 57 Predictive Toxicology 57 Report Identifies 57 Email Campaigns 57 Helps Improve 57 Cash Flow Positive 56 Addresses Growing 56 Achieves Record Sales 56 Regains NASDAQ 56 Expands Reseller 56 Operationalizing 56 Outlines Strategies 56 Internationally Recognized 56 Reduced Risk 56 Accelerate Commercialization 56 Expands Commitment 56 Schizophrenia Treatment 56 Actions Needed 56 Announce Interoperability 56 Amplifies 56 Releases Enhanced 56 Glaucoma Treatment 56 Structure Function 56 Distribution Agreements 56 Momentum Builds 56 Prioritizes 56 Without Compromising 56 Solution Streamlines 56 Institutionalize 56 Enhance Customer 56 Ongoing Commitment 56 Rheumatoid Arthritis Drug 56 Improves Survival 56 AVI BioPharma Announces 56 Achieves Record Revenue 56 Verifies 56 First Patient Enrolled 56 Seasonal Influenza 56 Significant Reduction 56 Mitigates 56 Sixth Consecutive Month 56 Quarrel Over 56 Makes Headway 56 Demonstrates Significant 56 Widespread Adoption 56 Achieves Positive 56 Provide Enhanced 56 Who Underwent 56 Revised Upward 56 Explosive Growth 56 Retains Leading 56 Medicure Announces 56 Prostate Cancer Patients 56 Consolidation Continues 56 Offers Unprecedented 56 Healthnostics Announces 56 Measurement Specialties Announces 56 Sensor Fusion 56 Competitive Position 56 Site Redesign 56 Not Disclosed 56 Must Adapt 56 Trade Pacts 56 Medication Adherence 56 Increases Commitment 56 Automated Compliance 56 Flexible Affordable 56 Study Analyzes 56 Issued Patent 56 Furthers Its 56 Connectyx Announces 56 Core Competencies 56 Metabolic Disorder 56 Continues Momentum 56 Panel Advises 56 Successfully Completed 56 Enhance Shareholder Value 56 Achieve Meaningful Use 56 Deliver Unprecedented 56 Less Costly 56 Differentiators 56 Panel Examines 56 Jointly Offer 56 Launches Expanded 56 Structured Content 56 Image Manipulation 56 Human Monoclonal Antibodies 56 Enhance Patient 56 Biopharmaceutical Industry 56 Variable Annuity Sales 56 PDL BioPharma Announces 56 Provides Clarification 56 Fundamental Shift 56 Efficiently Manage 56 Successful Deployment 56 Strengthens Its 56 Monetizes 56 Antipsychotic Drug 56 Receives ISO #:# [002] 56 Report Assesses 56 Examines Impact 56 Terminate Merger 56 Contract Signings 56 Demonstrates Statistically Significant 56 Vertebral Fracture 56 Caution Urged 56 Jointly Announce 56 FDA Approvals 56 Electronic Submission 56 Significantly Improve 56 StockGuru.com Announces Profile 56 Gathers Steam 56 Interoperate 56 Multiple Fronts 56 ETO MES 56 ValiMed TM 56 Saves Money 56 Stakeholder Opinions 56 Diagnostic Tests 56 Competitive Differentiator 56 Nanophase Announces 56 Ensure Compliance 56 Reduces Risk 56 GRAS Status 56 Zcom Networks Announces 56 Glucose Monitoring 56 Creates Unique 56 Treatment Reduces 56 Patient Adherence 56 Organizational Structure 56 Announces Enhancements 56 Achieves Prestigious 56 Asthma Treatment 56 ANADIGICS Announces 56 Emission Reductions 56 Heart Transplant Recipients 56 Payment Methods 56 Debit Card Processing 56 Sharpens Focus 56 Acne Drug 56 Regulatory Developments 56 Gastrointestinal Disorders 56 Reduce Expenses 56 Delivers Strong 56 Seminar Focuses 56 Brain Metastases 56 Gain Competitive Advantage 56 Enhanced Functionality 56 Strengthen Presence 56 Vetting Process 56 Improves Quality 56 Improve Quality 56 Accounts Payable Automation 56 Clinical Validation 56 Conductive Polymers 56 Turbocharge 56 Receives CE Marking 56 Proves Successful 56 Improved Usability 56 Royalty Rates 56 Receives URAC 56 Systemic Delivery 56 Carotid Artery Stenting 56 Fingerprint Biometrics 56 Improving Efficiency 56 Value Propositions 56 Newly Merged 56 Achieves Certification 56 Enhanced Online 56 Greatly Improves 56 Highest Priority 56 Amends Agreement 56 Scaling Back 56 Randomized Clinical Trials 56 Improving Profitability 56 Shifts Toward 56 Unique Challenges 56 Terminates Contract 56 Approach Needed 56 Expands Footprint 56 Treating Heart Failure 56 Fourth Consecutive Year 56 Improved Outcomes 56 Terminate Agreement 55 Lung Cancer Drug 55 Breast Ovarian Cancer 55 Wizzard Software Announces 55 Capsules CII 55 Market Penetration 55 Lowers Costs 55 Distinguishes 55 Lung Cancer Vaccine 55 Launches Unique 55 NDA Submission 55 Broadens Reach 55 Announces Affiliation 55 Guidelines Issued 55 Shows Promising 55 Growing Faster Than 55 Handset Manufacturers 55 Reconfirms 55 Study Explores 55 TenFold Announces 55 Forges Ahead 55 BIOLASE Announces 55 Clinical Outcome 55 Celebrates Successful 55 Study Examines 55 Randomized Controlled Trials 55 Achieves Milestone 55 Meet Stringent 55 Enhance User Experience 55 Therapy Improves 55 Retention Strategies 55 Acacia Subsidiary 55 Collaboration Tool 55 Provider Selects 55 Increased Efficiency 55 Targeted Ads 55 Interactive Digital Signage 55 Calculator Helps 55 Computerize 55 Effort Aims 55 Widely Available 55 Protects Customers 55 Increase Efficiencies 55 Award Recognises 55 Purchasing Decisions 55 Underscores Commitment 55 Unique Approach 55 Reaffirm Commitment 55 Prove Effective 55 Antitumor 55 Results Confirm 55 Develops Breakthrough 55 Vendor Selection 55 Announces Rebranding 55 Successfully Concludes 55 Phenomenal Growth 55 Growing Importance 55 Laryngeal Cancer 55 MEGA GRC 55 Combo Therapy 55 Visibility Into 55 Breastfeeding Moms 55 ESCO Announces 55 Bush Embraces Pause 55 Unveils Revolutionary 55 Regulatory Submissions 55 Localized Prostate Cancer 55 Help Manage 55 Identifies Potential 55 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 55 Patient Enrollment 55 Clinical Trial Enrollment 55 Novel Therapies 55 Will Overtake 55 Harsh Interrogation 55 PRACTICE MANAGEMENT 55 Solution Integrates 55 Pandemic Influenza Vaccines 55 Newly Expanded 55 KEMET Announces 55 FOR AN OPEN 55 Catalyze 55 Immunomedics Announces 55 Boost Efficiency 55 Hepatitis C Treatment 55 Trend Toward 55 Diminishes 55 Deliver Exceptional 55 Expanded Coverage 55 Expand Capabilities 55 Provides Update Regarding 55 Obtains Exclusive Rights 55 Significantly Strengthens 55 Increases Productivity 55 Continues Expansion 55 Free Ad Supported 55 Antidepressants Linked 55 Device Maker 55 Being Readied 55 Fast Growing 55 Receives Favorable 55 Aethlon Medical Releases 55 Content Outline 55 Eligibility Verification 55 Deliver Innovative 55 Vaccine Adjuvants 55 Provisioning Solution 55 Anytime Anywhere Access 55 Transdermal Delivery 55 Website Dedicated 55 Awarded GSA 55 Multivendor 55 Gout Drug 55 Proactive Approach 55 Introduces Breakthrough 55 Provides Guidance 55 Clarifies Position 55 HIPAA EDI 55 LightPath Technologies Announces 55 Milestone Achieved 55 Strengthens Commitment 55 Helps Identify 55 Announce Commencement 55 Accelerates 55 Settle Patent Litigation 55 Celebrates Decade 55 Analytics Capabilities 55 Recurring Revenue 55 Tracking Tool 55 Gold Nanorods 55 Patient Populations 55 Functional Outcomes 55 Air Cargo Screening 55 Enhances Productivity 55 Long Term Outcomes 55 Password Protected 55 Facilitates 55 Leadership Competencies 55 Begins Shipment 55 Strengthens Relationship 55 Reaches Profitability 55 Client Roster 55 Non Invasive Treatment 55 AurSCOPE 55 Deepened 55 Reduces Cost 55 -0 - 55 Presents Webinar 55 Significantly Reduces 55 Demonstrates Interoperability 55 Survey Uncovers 55 Document Composition 55 Dipping Into 55 Inhaled Nitric Oxide 55 Demonstrates Efficacy 55 Achieves Highest 55 Workflow Module 55 Improve Productivity 55 Cautious Optimism 55 Molecular Diagnostic Test 55 Appears Safe 55 JAK Inhibitor 55 Delivers Next Generation 55 - Aarkstore Enterprise [002] 55 Milestone Reached 55 IDEXX Laboratories Announces 55 Shoring Up 55 Steady Decline 55 Delivers Robust 55 Expands Relationship With 55 Remain Committed 55 Temporarily Suspends 55 Wide Array 55 AvalonBay Communities Announces 55 Recruitment Process 55 Device Helps 55 Pacific Rubiales Announces 55 Completes Transition 55 Electronic Prescribing 55 Doubles Size 55 Rotavirus Vaccine 55 Content Monetization 55 Showed Significant 55 Most Widely Used 55 Outlines Priorities 55 SOA Deployments 55 Product Rollout 55 Seriously Flawed 55 Granted Orphan Drug 55 Workflow Solution 55 Enters Joint Venture 55 Receives URAC Accreditation 55 Biologic Drugs 55 Reinforces Leadership 55 Initiates Clinical Trials 55 Protein Biomarker 55 Radiation Exposure 55 Gene Variants 55 Gaining Momentum 55 Shows Efficacy 55 Vastly Different 55 Extends Capabilities 55 Directly Into 55 Genetic Defect 55 Demystify 55 Expand Offerings 55 Surgical Procedures 55 Standardize 55 Going Smoothly 55 Successfully Completes Phase 55 Achieves Record Revenues 55 Misonix Announces 55 NuMobile NUBL 55 Positively Impact 55 Cost Effectively 55 Study Concludes 55 Signs Definitive Agreements 55 Makes Significant 55 Live Attenuated 55 Nanoemulsion 55 Prospects Dim 55 Lay Groundwork 55 Clinically Significant 55 Study Demonstrates 55 Nuclear Intentions 55 Broadens Scope 55 Pre Negotiated 55 Improves Workflow 55 Osteoarthritis Pain 55 Generic Medications 55 Competitive Differentiation 55 Expert Discusses 55 Provides Unparalleled 55 RFID Tagging 55 Closer Ties 55 Sees Continued 55 Double Digit Revenue 55 Growth Accelerates 55 Antidepressant Treatment 55 EntreMed Presents 55 Steep Rise 55 Surpasses Milestone 55 Senetek PLC Announces 55 Initial Shipment 55 Cuts Threaten 55 Gets Thumbs Down 55 Could Save Lives 55 Electronic Prescriptions 55 IND Filing 55 Prostate Cancer Vaccine 55 Underscores Importance 55 TB Vaccine 55 Improves Efficiency 55 Unsolicited Proposal From 55 Distribution Channels 55 Nears Launch 55 Insulin Pen 54 Improves Outcomes 54 Improve Patient Outcomes 54 Overestimated 54 Announce Intention 54 Expand Scope 54 Viable Alternative 54 Global Reseller Agreement 54 NASA Bioreactor 54 Gain Competitive Edge 54 Develops Novel 54 Less Than Half 54 Demonstrates Potential 54 Innate Immune 54 Negative Effects 54 Forges Strategic 54 Generated Content 54 Statin Drugs 54 Boosts Capacity 54 Genetic Testing 54 Improving Patient 54 Content Aggregation 54 Build Customer Loyalty 54 Sustained Reduction 54 Nearshore Outsourcing 54 Affirms Commitment 54 Highlight Importance 54 Substantially Increases 54 Expands Reach 54 Liver Toxicity 54 OneForce 54 Initiate Clinical Trial 54 CCID Consulting Analyzes 54 PREVU x LT 54 Gathers Momentum 54 Provides Enhanced 54 Increases Efficiency 54 Launches Enhanced 54 Proposed Rule Changes 54 Panel Faults 54 Growth Oriented 54 Effective Approach 54 Lung Cancer Survival 54 Collaborative Approach 54 Report Outlines 54 Taxonomies 54 Impairs 54 Image Guided 54 Long Term Viability 54 Could Undermine 54 Highlights Importance 54 ThermoGenesis Announces 54 Prolongs Life 54 Deep Venous Thrombosis 54 Antitumor Activity 54 Regulatory Clearance 54 STERIS Corporation Announces 54 Continuous Monitoring 54 Overcome Challenges 54 Introduces Enhanced 54 Receives Positive 54 Kaydon Corporation Announces 54 Increased Profitability 54 54 Aeolus Pharmaceuticals Announces 54 Complete Merger 54 Realigned 54 Incentivize 54 VIVUS Announces 54 Third Consecutive Quarter 54 Ad Targeting 54 Pneumonia Vaccine 54 Insulin Sensitivity 54 Ignites Debate 54 Rules Eased 54 Proxy Proposals 54 Issues Guidance 54 Anti Tumor 54 Sees Significant 54 Resolve Dispute Over 54 Parenteral Nutrition 54 Skin Lesions 54 Face Obstacles 54 Clears Path 54 Invest Heavily 54 Unveils Groundbreaking 54 Contract Renewals 54 Location Enabled 54 Stem Cell Treatment 54 Launches Next Generation 54 Gain Traction 54 Sexual Satisfaction 54 Less Invasive 54 Positively Impacts 54 Fully Functional 54 Sees Dramatic 54 Immune Cell 54 Collaboration Capabilities 54 Licensing Pact 54 Number Porting 54 Diagnostic Procedures 54 Obtains Exclusive 54 Optim Data 54 Upgrade Path 54 Clarification Regarding 54 StockSource.us Reports 54 Seamless Connectivity 54 Antibiotic Resistant 54 Announces Immediate Availability 54 Improve Energy Efficiency 54 Highly Competitive 54 Underserved Areas 54 Poses Serious 54 Statistically Significant 54 Untapped Potential 54 Patents Issued 54 Enhances Customer 54 VoIP Softphone 54 Testosterone Gel 54 Highlights Include 54 Diabetic Foot Ulcer 54 Pared Down 54 Dynamic Routing 54 Extend Relationship 54 Productivity Enhancements 54 Identifies Key 54 Boosts Efficiency 54 Submits Proposal 54 Competition Heats Up 54 i Lytics i Lytics 54 Sleep Disturbances 54 Reduces Costs 54 Deliver Comprehensive 54 Fully Prepared 54 Growth Trajectory 54 Critical Component 54 Key Factors Influencing 54 Diagnostic Criteria 54 Extend Partnership 54 Significantly Increases 54 Battle Intensifies 54 Re Affirms 54 Platform Enables 54 Consolidates Operations 54 Schweitzer Mauduit Announces 54 Demonstrates Long Term 54 Growth Slowing 54 Modernizes 54 Secures Patent 54 Study Underscores 54 Strengthens 54 Creating Compelling 54 Breast Exams 54 Improve Operational Efficiency 54 Radically Change 54 Favorable Ruling 54 Supply Chain Efficiencies 54 Inhaled Corticosteroids 54 Breast Density 54 Blood Pressure Drug 54 Referenced EEG 54 DIAGNOS Announces 54 Valuable Tool 54 NYSE Amex Listing 54 MMR Vaccine 54 Nasdaq Delisting Notice 54 Addressable Advertising 54 Deliver Enhanced 54 Attract Retain 54 Tumor Cell 54 Updates Shareholders 54 Repositions 54 Survival Benefit 54 Stereotaxis Announces 54 MAIN FACTS 54 Rise Dramatically 54 Workforce Productivity 54 Personalizes 54 Nearly Doubled 54 Proves Effective 54 Faces Obstacles 54 Redesigns Website 54 Renewed Commitment 54 eLoyalty Announces 54 Employee Referral 54 Increased Productivity 54 URAC Accreditation 54 Secures Financing 54 Helps Smokers Quit 54 Important Milestone 54 Seventh Consecutive Year 54 TELEPERFORMANCE 54 Differs From 54 Receives Patent 54 Successfully Launched 54 ACORD Standards 54 Face Hurdles 54 Study Uncovers 54 Uniquely Positioned 54 Pre Arranged 54 Hedge Funds Private Equity 54 Fast Tracked 54 Boost Productivity 54 Ownership Structure 54 Breast Tumor 54 Sweeping Changes 54 Expand Collaboration 54 Improve Efficiencies 54 Fifth Consecutive Year 54 Becoming Obsolete 54 Announce Collaboration Agreement 54 Establishes Strategic 54 Challenges Posed 54 Automation Capabilities 54 Customer Segmentation 54 Reduces Debt 54 LegalKEY R 54 Blood Stem Cells 54 Announces Profitable 54 Heterogeneity 54 Lifts FY# 54 Passenger Screening 54 Microfluidic Device 54 Achieves Breakthrough 54 Actively Managed ETFs 54 Chart Presentation 54 Deliverables 54 Psychographic 54 Long Term Survival 54 Vertebral Fractures 54 Interferes 54 TriCo Bancshares Announces 54 Retools 54 Ovarian Cancer Treatment 54 HPV Vaccination 54 Unifies 54 layouts xlviewer.aspx 54 Renewed Effort 54 Attained 54 Next Generation Optical 54 Too Costly 54 Neoadjuvant Chemotherapy 54 Breast Tissue 54 Imported Drugs 54 Imaging Techniques 54 Heska Announces 54 Prioritized 54 Nears Decision 54 #.#.#.#.# [004] 54 Resource Utilization 54 Gene Expression Analysis 54 Enterprisewide 54 Kidney Donors 54 Suboptimal 54 Hiring Spree